Nanosensors for regenerative medicine

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Nanotechnology

Background:

• Assessing implanted therapeutic cells is crucial for clinical translation.
• Current methods like histology have limitations: end-point analysis, high cost, long preparation, lack of real-time monitoring, and ethical concerns.
• Genetic engineering for cell tracking is complex, costly, and carries risks of cell dysfunction.

Purpose of the Study:

• To review nanosensor technology for tracking therapeutic cells.
• To highlight applications of nanosensors in regenerative medicine and preclinical research.
• To demonstrate how nanosensors can overcome limitations of current cell assessment techniques.

Main Methods:

• Review of existing literature on nanosensor technology.
• Classification and discussion of nanosensor types and evolution.
• Exploration of nanosensor applications in monitoring cell behavior, host response, and bioprocesses.

Main Results:

• Nanosensors provide a simple, cost-effective, and non-genetic alternative for cell tracking.
• Nanosensors enable real-time monitoring of cell location, status, and function.
• Applications include monitoring post-transplantation cells, host response to biomaterials, and optimizing cell bioprocesses.

Conclusions:

• Nanosensor technology is a promising tool for preclinical assessment of therapeutic cells.
• Incorporating nanosensors can significantly expedite the development of cell-based regenerative medicine.
• Nanosensors offer a versatile and efficient approach to address current challenges in cell therapy research.